Search Within

William Pao

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (11)
Groups
  1. Epidemiology and Biostatistics (27)
  2. Biostatistics Service (24)
  3. Department of Pathology and Laboratory Medicine (20)
  4. GSK Faculty (20)
  5. Human Oncology and Pathogenesis Program (20)
  6. Tow Center for Developmental Oncology (TCDO) (20)

More Groups

People
  1. Marc Ladanyi (19)
  2. Mark Kris (16)
  3. Valerie Rusch (16)
  4. Venkatraman Seshan (14)
  5. Maureen Zakowski (12)
  6. Ronglai Shen (8)

More People

Years
  1. 2011 (1)
  2. 2010 (3)
  3. 2009 (10)
  4. 2008 (3)
  5. 2007 (3)
  6. 2006 (4)

More Years

Publications
  1. Clinical Cancer Research (6)
  2. Journal of Clinical Oncology (5)
  3. Journal of Thoracic Oncology (5)
  4. Cancer Research (2)
  5. Cancer (1)
  6. JNCI: Journal of the National Cancer Institute (1)

More Publications

Publishers
  1. American Association for Cancer Research (8)
  2. American Society of Clinical Oncology (5)
  3. Elsevier Inc. (5)
  4. Nature Publishing Group (3)
  5. American Society for Clinical Investigation (1)
  6. National Academy of Sciences (1)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-lGF-1R antibody (R1507)
    Journal Article

    Gong, Y.; Yao, E.; Shen, R.; Goel, A.; Arcila, M.; Teruya-Feldstein, J.; Zakowski, M. F.; Frankel, S.; Peifer, M.; Thomas, R. K.; more...
    PLoS ONE (2009)

    Fulltext@MSK | Save
  • Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas
    Journal Article

    Girard, N.; Shen, R.; Guo, T.; Zakowski, M. F.; Heguy, A.; Riely, G. J.; Huang, J.; Lau, C.; Lash, A. E.; Ladanyi, M.; more...
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers
    Journal Article

    Girard, N.; Ostrovnaya, I.; Lau, C.; Park, B.; Ladanyi, M.; Finley, D.; Deshpande, C.; Rusch, V.; Orlow, I.; Travis, W. D.; more...
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors
    Journal Article

    Chitale, D.; Gong, Y.; Taylor, B. S.; Broderick, S.; Brennan, C.; Somwar, R.; Golas, B.; Wang, L.; Motoi, N.; Szoke, J.; more...
    Oncogene (2009)

    Fulltext@MSK | Save
  • An integrated analysis of gene expression, copy number alterations, and kinase pathway mutations in lung adenocarcinoma reveals frequent loss of the MAPK phosphatase Gene DUSP4 in EGFR mutant tumors
    Meeting Abstract

    Chitale, D.; Gong, Y.; Broderick, S.; Brennan, C.; Taylor, B. S.; Somwar, R.; Wang, L.; Motoi, N.; Szoke, J.; Sander, C.; more...
    Laboratory Investigation (2008)

    Fulltext@MSK | Save
  • An integrated analysis of gene expression, copy number alterations, and kinase pathway mutations in lung adenocarcinoma reveals frequent loss of the MAPK phosphatase gene DUSP4 in EGFR mutant tumors
    Meeting Abstract

    Chitale, D.; Gong, Y.; Broderick, S.; Brennan, C.; Taylor, B. S.; Somwar, R.; Wang, L.; Motoi, N.; Szoke, J.; Sander, C.; more...
    Modern Pathology (2008)

    Fulltext@MSK | Save
  • Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma
    Journal Article

    Marks, J. L.; Broderick, S.; Zhou, Q.; Chitale, D.; Li, A. R.; Zakowski, M. F.; Kris, M. G.; Rusch, V. W.; Azzoli, C. G.; Seshan, V. E.; more...
    Journal of Thoracic Oncology (2008)

    Fulltext@MSK | Save
  • Integrated genomic analysis of lung adenocarcinomas identifies loss of the MAPK phosphatase gene DUSP4 in most EGFR mutant tumors
    Meeting Abstract

    Broderick, S. R.; Chitale, D.; Motoi, N.; Gong, Y.; Pao, W.; Venkatraman, E.; Rusch, V.; Brennan, C.; Gerald, W.; Ladanyi, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • EGFR and KRAS mutations are molecular predictors of survival in resected lung adenocarcinoma
    Meeting Abstract

    Marks, J. L.; Broderick, S.; Seshan, V. E.; Zakowski, M. F.; Li, A.; Wilson, R.; Kris, M. G.; Ladanyi, M.; Rusch, V. W.; Pao, W.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Prospective trial of preoperative gefitinib to correlate response with EGFR exon 19 and 21 mutations and to select patients for adjuvant gefitinib
    Meeting Abstract

    Kris, M. G.; Pao, W.; Zakowski, Maureen F; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save